These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16806016)

  • 1. [Biologic activity of bispecific single chain antibody against human gamma-seminoprotein and CD3 molecule].
    Wang D; Wang H; Wu GJ; Wu WZ; Yang SL; Lin WH; Tan JM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):500-3. PubMed ID: 16806016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on p53 tetramerization domain in improving functional affinity and biological activity of antibody].
    Wang D; Wu GJ; Tan JM; Wang H
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):479-82. PubMed ID: 15854555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction and expression of anti-CD3/anti-prostate-cancer bispecific single-chain antibody].
    Wang D; Wu GJ; Wang H; Yang SL; Wu WZ; Xu TZ; Tan JM
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1292-5. PubMed ID: 12930679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of different interchain linkers on biological activity of an anti-prostate cancer single-chain bispecific antibody.
    Hao CH; Han QH; Shan ZJ; Hu JT; Zhang N; Zhang XP
    Theor Biol Med Model; 2015 Aug; 12():14. PubMed ID: 26246000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of biologic activity of two anti-PSA/anti-CD3 bispecific single-chain antibodies].
    Wang D; Wu GJ; Wang H; Wu WZ; Yang SL; Tan JM
    Zhonghua Nan Ke Xue; 2007 Jan; 13(1):8-12. PubMed ID: 17302025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells.
    Bühler P; Wolf P; Gierschner D; Schaber I; Katzenwadel A; Schultze-Seemann W; Wetterauer U; Tacke M; Swamy M; Schamel WW; Elsässer-Beile U
    Cancer Immunol Immunother; 2008 Jan; 57(1):43-52. PubMed ID: 17579857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancer.
    Katzenwadel A; Schleer H; Gierschner D; Wetterauer U; Elsässer-Beile U
    Anticancer Res; 2000; 20(3A):1551-5. PubMed ID: 10928069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody.
    Fortmüller K; Alt K; Gierschner D; Wolf P; Baum V; Freudenberg N; Wetterauer U; Elsässer-Beile U; Bühler P
    Prostate; 2011 May; 71(6):588-96. PubMed ID: 20945402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo retargeting of T cell effector function by recombinant bispecific single chain Fv (anti-CD3 x anti-idiotype) induces long-term survival in the murine BCL1 lymphoma model.
    De Jonge J; Heirman C; de Veerman M; Van Meirvenne S; Moser M; Leo O; Thielemans K
    J Immunol; 1998 Aug; 161(3):1454-61. PubMed ID: 9686611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression, identification and bioactivity characterization of an anti-CD3/anti-CD20 bispecific single-chain antibody].
    Yu R; Li SC; Wu BC; Liu H; Ye LL; Chen ZL
    Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):289-93. PubMed ID: 16013492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction and expression of diabody [CD3 x Pgp] without Etag].
    Liu JN; Gao YD; Wang JH; Shao XF; Fan DM; Ji Q; Xiong DS; Yang CZ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):946-9. PubMed ID: 17908506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activities of PSMA×CD3 diabodies by redirected T-cell lysis of prostate cancer cells.
    Baum V; Bühler P; Gierschner D; Herchenbach D; Fiala GJ; Schamel WW; Wolf P; Elsässer-Beile U
    Immunotherapy; 2013 Jan; 5(1):27-38. PubMed ID: 23256796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
    Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
    MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells.
    Guettinger Y; Barbin K; Peipp M; Bruenke J; Dechant M; Horner H; Thierschmidt D; Valerius T; Repp R; Fey GH; Stockmeyer B
    J Immunol; 2010 Feb; 184(3):1210-7. PubMed ID: 20042573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and immunological activity of an anti-CD3×VEGFR2 bispecific single-chain antibody].
    Dai LJ; Yan CW; Li SZ; Chen L; Li XY; Shan RH; Yu XW; Tang XB
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Aug; 27(8):883-6. PubMed ID: 21806887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retargeting of CTL by an efficiently refolded bispecific single-chain Fv dimer produced in bacteria.
    Kurucz I; Titus JA; Jost CR; Jacobus CM; Segal DM
    J Immunol; 1995 May; 154(9):4576-82. PubMed ID: 7536774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction, expression and functional characterization of single chain variable fragments (scFv) against human CD33 antigen].
    Chen XJ; Wang Y; Qu H; Ge XS; Zuo YF; Liao XL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1147-9. PubMed ID: 18062889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction and expression of anti-human CD3 single chain Fv antibody/human p53 tetramerization domain fusion gene].
    Wu GJ; Bai YJ; Wang D; Yu L; Wang Z; Wang H; Yao LB
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):560-2. PubMed ID: 15367347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics.
    Kipriyanov SM; Moldenhauer G; Schuhmacher J; Cochlovius B; Von der Lieth CW; Matys ER; Little M
    J Mol Biol; 1999 Oct; 293(1):41-56. PubMed ID: 10512714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant bispecific single-chain Fv antibody against HLA class II and FcgammaRIII (CD16) triggers effective lysis of lymphoma cells.
    Bruenke J; Fischer B; Barbin K; Schreiter K; Wachter Y; Mahr K; Titgemeyer F; Niederweis M; Peipp M; Zunino SJ; Repp R; Valerius T; Fey GH
    Br J Haematol; 2004 Apr; 125(2):167-79. PubMed ID: 15059139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.